Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 108514
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.108514
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.108514
Figure 1 Colorectal cancer progression and overexpression of stage-specific markers.
Above: Sporadic colorectal cancer characterized by the adenoma-carcinoma sequence. Below: Colitis-associated colorectal cancer characterized by the inflammation-dysplasia-carcinoma sequence. The two sequences differ in the overexpression of several markers, varying in frequency and timing. Image created with BioRender.com. CRC: Colorectal cancer; APC: Adenomatous polyposis coli; MSI: Microsatellite instability; COX-2: Cyclooxygenase-2; DCC: Deleted in colorectal cancer; PTEN: Phosphatase and tensin homolog; PI3KCA: Class A phosphoinositide 3-kinases; TGF: Transforming growth factor; TGFBR2: Transforming growth factor beta receptor 2.
- Citation: Catalano M, Mini E, Nobili S, Vascotto IA, Ravizza D, Amorosi A, Tonelli F, Roviello F, Roviello G, Nesi G. Ulcerative colitis and colorectal cancer: Pathogenic insights and precision strategies for prevention and treatment. World J Gastrointest Oncol 2025; 17(10): 108514
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/108514.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.108514
